Chromium(III) complexes with 2-(2′-pyridyl)imidazole: Synthesis, crystal structure and magnetic properties

The preparation, crystal structure and variable temperature-magnetic investigation of three 2-(2′-pyridyl)imidazole-containing chromium(III) complexes of formula PPh₄[Cr(pyim)(C₂O₄)₂]·H₂O (1), AsPh₄[Cr(pyim)(C₂O₄)₂]·H₂O (2) and [Cr₂(pyim)₂(C₂O₄)₂(OH₂)₂]·2pyim · 6H₂O (3) [pyim = 2-(2′-pyridyl)imidazole, , and ] are reported herein. The isomorphous compounds are made up of discrete [Cr(pyim)(C₂O₄)₂]⁻ anions, cations [X = P (1) and As (2)] and uncoordinated water molecules. The chromium environment in 1 and 2 is distorted octahedral with Cr-N and Cr-O bond distances varying in the ranges 2.040(3)-2.101(3) and 1.941(3)-1.959(3) Å, respectively. The angle subtended by the chromium(III) ion by the two didentate oxalate ligands cover the range 82.49(12)-82.95(12)°, values which are somewhat greater than those concerning the chelating pyim molecule [77.94(13) (1) and 78.50(13)° (2)]. Complex 3 contains discrete centrosymmetric [Cr₂(pyim)₂(C₂O₄)₂(OH)₂] neutral units where the two chromium(III) ions are joined by a di-μ-hydroxo bridge, the oxalate and pyim groups acting as peripheral didentate ligands. Uncoordinated water and pyim molecules are also present in 3 and they contribute to the stabilization of its structure by extensive hydrogen bonding and π-π type interactions. The values of the intramolecular chromium-chromium separation and angle at the hydroxo bridge in 3 are 2.9908(12) Å and 99.60(16)°, respectively. Magnetic susceptibility measurements of 1-3 in the temperature range 1.9-300 K show the occurrence of weak inter- (1 and 2) and intramolecular (3) antiferromagnetic couplings. The magnetic properties of 3 have been interpreted in terms of a temperature-dependent exchange integral, small changes of the angle at the hydroxo bridge upon cooling being most likely responsible for this peculiar magnetic behavior.     

Bis(pyrazolyl) palladium(II), platinum(II) and gold(III) complexes: Syntheses, molecular structures and substitution reactions with l-cysteine

A series of pyrazolyl palladium(II), platinum(II) and gold(III) complexes, [PdCl₂(3,5-R₂bpza)] {R = H (1), R = Me (2), bpza = bis-pyrazolyl acetic acid}, [PtCl₂(3,5-R₂bpza)] {R = H (3a), R = Me (4)}, [AuCl₂(3,5-R₂bpza)]Cl {R = H (5a), R = Me (6a)} and [PdCl₂(3,5-R₂bpzate)] {R = Me (7)} have been synthesised and structurally characterised. Single crystal X-ray crystallography showed that the pyrazolyl ligands exhibit N^N-coordination with the metals. Anticancer activities of six complexes 1-6a were investigated against CHO cells and were found to have low activities. Substitution reactions of selected complexes 1, 2, 3a and 5a with l-cysteine show that the low anticancer activities compounds and that the rate of substitution with sulfur-containing compounds is not the cause of the low anticancer activities.     

Supramolecular diversity and magnetic properties of novel heterometallic Cu(II)/Cr(III) complexes prepared from copper powder, Reineckes salt and ethylenediamine

Three novel heterometallic complexes [Cu(en)₂Cr(NCS)₄(NH₃)₂][Cr(NCS)₄(NH₃)₂] · 6dmf (1), [Cu(en)₂Cr(NCS)₄(NH₃)₂](OAc) (2) and [{Cu(en)₂}₃{Cr(NCS)₄(NH₃)₂}₂(NCS)₂](NCS)₂ (3) have been synthesized in a one-pot reaction from copper powder, Reineckes salt, NH₄X [X⁻ = OAc⁻ (2), NCS⁻ (3)] in a dmf (1) or CH₃CN (2, 3) solution of ethylenediamine (en). X-ray studies showed that 1 and 2 consist of cationic polymeric chains, formed by and building blocks that bridged through thiocyanate anions. In both complexes, distinct hydrogen bonds are present and serve to increase the dimensionality of the compound from one to two (in 1) or three (in 2). The main structural feature of 3 is the pentanuclear Cu₃Cr₂ cation which is H-bonded with uncoordinated thiocyanate groups generating a 3D supramolecular assembly. The shortest Cu?Cr distances are 5.840(1) Å for 1, 5.856(1) and 6.018(3) Å for 2 and 6.009(9) and 6.465(9) Å for 3. Compounds 1 and 2 are essentially paramagnets whereas compound 3 shows a weak antiferromagnetic coupling. The magnetic properties are simulated and discussed in terms of the structural features.     

Iron(III), chromium(III) and cobalt(II) complexes with squarate: Synthesis, crystal structure and magnetic properties

The preparation and variable temperature-magnetic investigation of three squarate-containing complexes of formula [Fe₂(OH)₂(C₄O₄)₂(H₂O)₄]·2H₂O (1) [Cr₂(OH)₂(C₄O₄)₂(H₂O)₄]·2H₂O (2) and [Co(C₄O₄)(H₂O)₄]_n (3) [H₂C₄O₄ = 3.4-dihydroxycyclobutene-1,2-dione (squaric acid)] together with the crystal structures of 1 and 3 are reported. Complex 1 contains discrete centrosymmetric [Fe₂(OH)₂(C₄O₄)₂(H₂O)₄] diiron(II) units where the iron pairs are joined by a di-μ-hydroxo bridge and two squarate ligands acting as bridging groups through adjacent oxygen atoms. Two coordinated water molecules in cis position complete the octahedral environment at each iron atom in 1. The iron-iron distance with the dinuclear unit is 3.0722(6) Å and the angle at the hydroxo bridge is 99.99(7)°, values which compare well with the corresponding ones in the isostructural compound 2 (2.998 Å and 99.47°) whose structure was reported previously. The crystal structure of 3 contains neutral chains of squarato-O¹,O³-bridged cobalt(II) ions where four coordinated water molecules complete the six-coordination at each cobalt atom. The cobalt-cobalt separation across the squarate bridge is 8.0595(4) Å. A relatively important intramolecular antiferromagnetic coupling occurs in 1 whereas it is very weak in 2, the exchange pathway being the same [J = −14.4 (1) and −0.07 cm⁻¹ (2), the spin Hamiltonian being defined as ]. A weak intrachain antiferromagnetic interaction between the high-spin cobalt(II) ions occurs in 3 (J = −0.30 cm⁻¹). The magnitude and nature of these magnetic interactions are discussed in the light of their respective structures and they are compared with those reported for related systems.     

Supramolecular isomers of lanthanides(III): Synthesis, crystal structures and luminescent properties

Six lanthanide coordination polymers La₂(1,4-BDOA)₂(OX)(H₂O) (1), Ln₂(1,4-BDOA)₂(OX)(H₂O) [Ln = La (2); Ln = Pr (3); Ln = Sm (4); Ln = Eu (5); Ln = Tb (6)], [BDOA = benzene-1,4-dioxydiacetate; OX = oxalate] had been prepared under hydrothermal conditions, which were characterized by elemental analysis, infrared spectroscopy, thermogravimetric analysis, and single-crystal X-ray diffraction. Compounds 1-6 crystallize in a triclinic system, space group ; compounds 1 and 2 are true structural supramolecular isomers based on BDOA ligands constructed from different acid effects; compounds 2-5 are isostructural and exhibit new 3D 12-connected topological networks, which are the same as the topological structure of 6, while 1 shows another 3D 11-connected topological architecture. Furthermore, the luminescent properties of 5 and 6 were studied.     

Synthesis of cobalt(III) complexes with novel open chain oxime ligands and metal-ligand coordination in aqueous solution

Cobalt(III) complexes with new open chain oxime ligands: N,N′-bis(2-hydroxyiminopropionyl)-1,2-aminoethane (H₂pen) and N,N′-bis(2-hydroxyiminopropionyl)-1,3-diaminopropane (H₂pap) have been investigated. Single crystals of Co(papH₋₁)(Im₂)·CH₃OH (1) and Co(papH₋₁)(MEA)₂·1.5H₂O (2) (where Im = imidazole, MEA = monoethanolamine) suitable for X-ray crystallography were grown by slow evaporation of methanol/water solutions at room temperature. The molecular structures have been determined using single-crystal X-ray diffraction methods. The potentiometric and spectrophotometric results in aqueous solution reveal that both of the open chain ligands show a very high efficacy in the coordination of Co(II) ions. As it has been indicated, differences between the two oxime ligands in complexing ability may be attributed to the longer -CH₂- chain in H₂pap and by that a better fit of the relatively large Co(II) ion to the accessible binding site. One of the complex species confirmed under inert atmosphere, namely of type Co(LH₋₁)⁻ (where L = pap or pen), has been shown as the “active” form, capable of dioxygen uptake followed by irreversible oxidation to Co(III).     

Synthesis and characterization of Fe(III)(3-CH3O-qsal)2PF6 · nH2O (n = 0, 2)

Compounds Fe^III(3-CH₃O-qsal)₂PF₆ · nH₂O (n = 0, 2) (1, 1 · 2H₂O) were synthesized and characterized: the structure of 1 and the magnetic properties of both compounds were determined. Compound 1 · 2H₂O presents properties characteristic of high-spin Fe(III), while 1 presents properties of low-spin Fe(III) with an onset of a gradual spin crossover at ca. 300 K.     

Cyclometalated rhodium(III) and iridium(III) complexes containing amino acids as N,O-chelates

The synthesis of bis-cyclometalated aminocarboxylato complexes [M(α-aminocarboxylato)(ptpy)₂] (M = Rh, 3, 4, 5; M = Ir, 6, 7, 8), ptpy = 2-(p-tolyl)pyridinato; aminocarboxylato = glycinato, l-alaninato, l-prolinato) from [{M(μ-Cl)(ptpy)₂}₂] (M = Rh, 1; M = Ir, 2) is described. The molecular structure of [Ir(l-alaninato)(ptpy)₂] (7) was confirmed by a single-crystal X-ray diffraction study. Compound 7 crystallized from methanol-iso-hexane in the space group P2₁. For 7 the two diastereoisomers Δ_Ir, S_C and Λ_Ir, S_C were found crystallizing twice per unit. Absorption and emission spectra were recorded. The rhodium compounds are weak yellow-green and the iridium species strong green emitters.     

Synthesis and spectroscopic properties of cobalt(III) complexes of some aroyl hydrazones: X-ray crystal structures of one cobalt(III) complex and two aroyl hydrazone ligands

Cobalt(III) complexes of diacetyl monooxime benzoyl hydrazone (dmoBH₂) and diacetyl monooxime isonicotinoyl hydrazone (dmoInH₂) have been synthesized and characterized by elemental analyses and spectroscopic methods. The X-ray crystal structures of the two hydrazone ligands, as well as that of the cobalt(III) complex [Co^III(dmoInH)₂]Cl·2H₂O, are also reported. It is found that in the cobalt(III) complexes the Co(III) ion is hexa-coordinated, the hydrazone ligands behaving as mono-anionic tridentate O,N,N donors. In the [Co^III(dmoInH)₂]Cl·2H₂O complex, the amide and the oxime hydrogens are deprotonated for both the ligands, while the isonicotine nitrogens are protonated. In the [Co^III(dmoBH)₂]Cl complex, only the amide nitrogens are deprotonated. It is shown that the additional hydrogen bonding capability of the isonicotine nitrogen results in different conformation and supramolecular structure for dmoInH₂, compared to dmoBH₂, in the solid state. Comparing the structure of the [Co^III(dmoInH)₂]Cl·2H₂O with that of the Zn(II) complex of the same ligand, reported earlier, it is seen that the metal ion has a profound influence on the supramolecular structure, due to change in geometrical dispositions of the chelate rings.     

Synthesis and characterization of three mononuclear Fe(III) complexes containing bipodal and tripodal ligands: X-ray molecular structure of the dichloro[N-propanamide-N,N-bis-(2-pyridylmethyl)amine]iron(III) perchlorate

In this work, we present the synthesis and characterization of three mononuclear iron(III) complexes: dichloro[N-propanamide-N,N-bis-(2-pyridylmethyl)amine]iron(III) perchlorate (1), trichloro[N-methylpropanoate-N,N-bis-(2-pyridylmethyl)amine]iron(III) (2) and trichloro[bis-(2-pyridylmethyl)amine]iron(III) (3). The complexes were characterized by cyclic voltammetry, conductivimetry, elemental analyses, and by electronic, infrared and Mössbauer spectroscopies. Complex 1 was also characterized by X-ray structural analysis, which showed an iron center coordinated to one amide, one tertiary amine, two pyridine groups and two chloride ions. While for 1 the X-ray molecular structure and the infrared spectrum confirm the coordination of the amide group by the oxygen atom, the infrared spectrum of 2 indicates that the ester group present in the ligand is not coordinated, resulting in a N₃Cl₃ donor set, similar to the one present in 3. However, in 3 there is a secondary amine while in 2 a tertiary amine exists. These structural differences result in distinguishable variations in the Lewis acidity of the iron center, which could be evaluated by the analysis of the redox potential of the complexes, as well as by Mössbauer parameters. Thus, the Lewis acidity decreases in the following order: 1 > 2 > 3. It is important to notice that 1 has the amide group coordinated to the iron center, a feature present in metalloenzymes as lipoxygenase and isopenicillin N synthase, and in a small number of mononuclear iron(III) complexes.     

Synthesis, characterizations and crystal structures of antimony(III) complexes with nitrogen-containing ligands

Six antimony adducts with N-donor neutral ligands (1,10-phenanthroline, 4,4′-bipyridine) have been obtained following the reaction of antimony halides with phenanthroline and 4,4′-bipyridine. By changing the solvent and stoichiometry, we obtained six different complexes, Sb(phen)Cl₃ (1), Sb(phen)Br₃ (2), Sb₂(phen)₄Br₈ (3) and Sb(bpy)Cl₃ (4), Sb(bpy)₂Cl₃ (5), Sb(bpyH · bpyH₂)Br₆ (6) (where phen = 1,10-phenanthroline, bpy = 4,4′-bipyridine). All the complexes have been characterized via elemental analysis, FT-IR and NMR (¹H, ¹³C) spectroscopy. The crystal structures of complexes 2, 3 and 6 have been determined by X-ray single crystal diffraction.The structural analysis show that the coordination sphere around antimony atom in complex 2 is a distorted square pyramid, coordinated by three bromine atoms and two nitrogen atoms from phen. In complex 3, the central antimony atom is six-coordinated through four bromine atoms and two nitrogen atoms forming a distorted octahedral geometry. Besides that, there are also uncoordinated 1,10-phenanthroline bonded by hydrogen bonds and π-π stacking interactions, which is rarely observed in previous reports. The crystal structure of complex 6 consists of bpyH · bpyH₂ trications and hexabromoantimonate trianions. The antimony atom in the anion has a distorted octahedral environment. Additionally, all complexes present a 3D framework built up by N-H?Br, C-H?Br and C-H?Cl weak hydrogen bonds interactions.     

Syntheses, structures, and properties of Co(III) complexes derived from polypyridine ligands containing one carboxamido nitrogen donor

Four cobalt(III) complexes containing the polypyridine pentadentate ligands N,N-bis(2-pyridylmethyl)amine-N′-ethyl-2-pyridine-2-carboxamide (PaPy₃H), N,N-bis(2-pyridylmethyl)amine-N′-[1-(2-pyridylethyl)acetamide (MePcPy₃H), and N,N-bis(2-pyridylmethyl)amine-N′-(2-pyridylmethyl)acetamide (PcPy₃H), have been synthesized. All three ligands bind the Co(III) center in the same fashion with the exception of loss of conjugation between the carboxamide moiety and the pyridine ring in the latter two. The structures of [(PaPy₃)Co(OH)][(PaPy₃)Co(H₂O)](ClO₄)₃ · 3H₂O (1), [(PaPy₃)Co(NO₂)](ClO₄) · 2MeCN (2), [(MePcPy₃)Co(MeCN)](ClO₄)₂ · 0.5MeCN (3), and [(PcPy₃)Co(Cl)](ClO₄) · 2MeCN (4) have been determined. These ligands with strong-field carboxamido N donor stabilize the +3 oxidation state of the Co center as demonstrated by the facile oxidation of the corresponding Co(II) complexes (prepared in situ) by H₂O₂, [Fe(Cp)₂](BF₄), or nitric oxide (NO). The Co-N_amido bond distances of 1-4 lie in the narrow range of 1.853-1.898 Å. ¹H NMR spectra of these complexes confirm the low-spin d⁶ ground states of the metal centers.     

Secondary ligand-metal interactions in rhodium(III) and iridium(III) phosphoramidite complexes

The synthesis, characterization, and application in asymmetric catalytic cyclopropanation of Rh(III) and Ir(III) complexes containing (S_a,R_C,R_C)-O,O′-[1,1′-binaphthyl-2,2′-diyl]-N,N′-bis[1-phenyl-ethyl]phosphoramidite (1) are reported. The X-ray structures of the half-sandwich complexes [MCl₂(C₅Me₅)(1,κP)] (M = Rh, 2a; M = Ir, 2b) show that the metal-phosphoramidite bond is significantly shorter in the Ir(III) analog. Chloride abstraction from 2a (with CF₃SO₃SiMe₃ or with CF₃SO₃Me) and from 2b (with AgSbF₆) gives the cationic species [MCl(C₅Me₅)(1,2-η-1,κP)]⁺ (M = Rh, 3a; M = Ir, 3b), which display a secondary interaction between the metal and a dangling phenethyl group (NCH(CH₃)Ph) of the phosphoramidite ligand, as indicated by NMR spectroscopic studies. Complexes 3a and 3b slowly decompose in solution. In the case of 3b, the binuclear species [Ir₂Cl₃(C₅Me₅)₂]⁺ is slowly formed, as indicated by an X-ray study. Preliminary catalytic tests showed that 3a cyclopropanates styrene with moderate yield (35%) and diastereoselectivity (70:30 trans:cis ratio) and with 32% ee (for the trans isomer).     

Iron(III) Schiff base complexes of arginine and lysine as netropsin mimics showing AT-selective DNA binding and photonuclease activity

Iron(III) complexes [Fe(L)₂]Cl (1-3), where L is monoanionic N-salicylidene-arginine (sal-argH for 1), hydroxynaphthylidene-arginine (nap-argH for 2) and N-salicylidene-lysine (sal-lysH for 3), were prepared and their DNA binding and photo-induced DNA cleavage activity studied. Complex 3 as its hexafluorophosphate salt [Fe(sal-lysH)₂](PF₆)·6H₂O (3a) was structurally characterized by single crystal X-ray crystallography. The crystals belonged to the triclinic space group P-1. The complex has two tridentate ligands in FeN₂O₄ coordination geometry with two pendant cationic amine moieties. Complexes 1 and 2 with two pendant cationic guanidinium moieties are the structural models for the antitumor antibiotics netropsin. The complexes are stable and soluble in water. They showed quasi-reversible Fe(III)/Fe(II) redox couple near 0.6 V in H₂O-0.1 M KCl. The high-spin 3d⁵-iron(III) complexes with μ_eff value of ∼5.9 μ_B displayed ligand-to-metal charge transfer electronic band near 500 nm in Tris-HCl buffer. The complexes show binding to Calf Thymus (CT) DNA. Complex 2 showed better binding propensity to the synthetic oligomer poly(dA)·poly(dT) than to CT-DNA or poly(dG)·poly(dC). All the complexes displayed chemical nuclease activity in the presence of 3-mercaptopropionic acid as a reducing agent and cleaved supercoiled pUC19 DNA to its nicked circular form. They exhibited photo-induced DNA cleavage activity in UV-A light and visible light via a mechanistic pathway that involves the formation of reactive hydroxyl radical species.     

Synthesis, characterization and preliminary cytotoxicity evaluation of five lanthanide(III)-plumbagin complexes

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone, H-PLN) was isolated from Plumbago zeylanica, the anticancer traditional Chinese medicine (TCM). Five new lanthanide(III) complexes of deprotonated plumbagin: [Y(PLN)₃(H₂O)₂] (1), [La(PLN)₃(H₂O)₂] (2), [Sm(PLN)₃(H₂O)₂]⋅H₂O (3), [Gd(PLN)₃(H₂O)₂] (4), and [Dy(PLN)₃(H₂O)₂] (5) were synthesized by the reaction of plumbagin with the corresponding lanthanide salts, in amounts equal to ligand/metal molar ratio of 3:1. The PLN-lanthanide(III) complexes were characterized by different physicochemical methods: elemental analyses, UV-visible, IR and ¹H NMR and ESI-MS (electrospray ionization mass spectrum) as well as TGA (thermogravimetric analysis). The plumbagin and its lanthanide(III) complexes 1-5, were tested for their in vitro cytotoxicity against BEL7404 (liver cancer) cell lines by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The five PLN-lanthanide (III) complexes 1-5 effectively inhibited BEL7404 cell lines growth with IC₅₀ values of 11.0 ± 3.5, 5.1 ± 1.3, 6.1 ± 1.1, 6.4 ± 1.3, and 9.8 ± 1.5 μM, respectively, and exhibited a significantly enhanced cytotoxicity compared to plumbagin and the corresponding lanthanide salts, suggesting a synergistic effect upon plumbagin coordination to the Ln(III) ion. The lanthanide complexes under investigation also exerted dose- and time-dependent cytotoxic activity. [La(PLN)₃(H₂O)₂] (2) and plumbagin interact with calf thymus DNA (ct-DNA) mainly via intercalation mode, but for [La(PLN)₃(H₂O)₂] (2), the electrostatic interaction should not be excluded; the binding affinity of [La(PLN)₃(H₂O)₂] (2) to DNA is stronger than that of free plumbagin, which may correlate with the enhanced cytotoxicity of the PLN-lanthanide(III) complexes.     

Imidazole derivatives of binuclear copper (II) and nickel (II) complexes incorporating bis(1,4,7-triazacyclononan-1-yl) ligands

A series of new binuclear copper (II) and nickel (II) complexes of the macrocyclic ligands bis(1,4,7-triazacyclononan-1-yl)butane (L^but) and bis(1,4,7-triazacyclononan-1-yl)-m-xylene (L^mx) have been synthesized: [Cu₂L^butBr₄] (1), [Cu₂L^but(imidazole)₂Br₂](ClO₄)₂ (2), [Cu₂L^mx(μ-OH)(imidazole)₂](ClO₄)₃ (3), [Cu₂L^but(imidazole)₄](ClO₄)₄ · H₂O (4), [Cu₂L^mx(imidazole)₄](ClO₄)₄ (5), [Ni₂ L^but(H₂O)₆](ClO₄)₄ · 2H₂O (6), [Ni₂L^but(imidazole)₆](ClO₄)₄ · 2H₂O (7) and [Ni₂L^mx (imidazole)₄(H₂O)₂](ClO₄)₄ · 3H₂O (8). Complexes 1, 2, 7 and 8 have been characterized by single crystal X-ray studies. In each of the complexes, the two tridentate 1,4,7-triazacyclononane rings of the ligand facially coordinate to separate metal centres. The distorted square-pyramidal coordination sphere of the copper (II) centres is completed by bromide anions in the case of 1 and/or monodentate imidazole ligands in complexes 2, 4 and 5. Complex 3 has been formulated as a monohydroxo-bridged complex featuring two terminal imidazole ligands. Complexes 6-8 feature distorted octahedral nickel (II) centres with water and/or monodentate imidazole ligands occupying the remaining coordination sites. Within the crystal structures, the ligands adopt trans conformations, with the two metal binding compartments widely separated, perhaps as a consequence of electrostatic repulsion between the cationic metal centres. The imidazole-bearing complexes may be viewed as simple models for the coordinative interaction of the binuclear complexes of bis (tacn) ligands with protein molecules bearing multiple surface-exposed histidine residues.     

Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes

Four related ruthenium(III) complexes, with the formula mer-[RuCl₃(dmso)(N−N)] (dmso = dimethyl sulfoxide; N−N = 2,2′-bipyridine (1), 1,10-phenantroline (2), dipyrido[3,2-f:2′,3′-h]quinoxaline (3) and dipyrido[3,2-a:2′,3′-c]phenazine (4)), have been reported. Complexes 3 and 4 are newly synthesized and characterized by X-ray diffraction. The hydrolysis process of 1-4 has been studied by UV-vis measurement, and it has been found that the extension of the N−N ligands can increase the stability of the complexes. The binding of these complexes with DNA has been investigated by plasmid cleavage assay, competitive binding with ethidium bromide (EB), DNA melting experiments and viscosity measurements. The DNA binding affinity is increased with the extension of the planar area of the N−N ligands, and complex 4 shows an intercalative mode of interaction with DNA. The in vitro anticancer activities of these compounds are moderate on the five human cancer cell lines screened.     

Synthesis and characterization of two stable paramagnetic octahedral chromium(IV) complexes with dianionic tridentate SNO donor ligands and of a chromium(III) complex with a ONO donor ligand

Two novel paramagnetic octahedral chromium(IV) complexes with dianionic tridentate SNO donor ligands containing extended π-system have been synthesized while only a paramagnetic octahedral chromium(III) complex is obtained when a related dianionic tridentate ONO donor ligand is used under similar conditions. These bischelate complexes [Cr(abtsal)₂] (1) (abtsalH₂ is the Schiff base of o-aminobenzenethiol and salicylaldehyde), [Cr(4-PhTSCsal)₂] · H₂O (2) (4-PhTSCsalH₂ is the Schiff base of 4-phenylthiosemicarbazide and salicylaldehyde) and K[Cr(sap)₂] · H₂O (3) (sapH₂ is the tridentate Schiff base of salicylaldehyde and o-aminophenol) are characterized by elemental analyses, magnetic moment measurements, IR, UV-Vis and EPR spectroscopic studies. Compound 3 has been structurally characterized by X-ray crystallography. Measured room temperature (RT) magnetic moment values are 2.98 BM for 1 and 2.83 BM for 2 indicating a d² system with a triplet ground state in both the cases. On the other hand, the magnetic moment value for 3 is found to be 3.74 BM at RT and is consistent with the presence of three unpaired electrons for a d³ Cr(III) ion. The magnetic moment values rule out the large spin-orbit coupling which is substantiated by the presence of RT EPR signals. Compounds 1 and 2 exhibit very similar powder EPR spectra at RT and LNT, which show the allowed transition ΔM_s = ±1 (g = 2.004 for both 1 and 2) as well as the “forbidden” half-field transition (ΔM_s = ±2) at g = 4.105 for 1 and g = 4.318 for 2, respectively. The X-band LNT frozen glass EPR spectrum of 1 in DMF shows the presence of zero-field split rhombic symmetry character, and results in the parameters g ≅ 2.0, D = 740 G, and E = 260 G. It suggests that the intensity of ΔM_s = ±2 forbidden transition is large due to the large D value. The X-band frozen glass EPR spectrum of compound 3 in DMF is found to be very similar to that reported for trans-[Cr(py)₄F₂]⁺ in DMF-H₂O-MeOH glass. The large difference (∼700 mV) in the reduction potential for the two octahedral complexes 1 (−1.40 V) and 3 (−0.70 V) is attributed to the difference in their metal ion oxidation states.     

Europium (III) complexes derived from carboxylic-substituted polychlorotriphenylmethyl radicals

Two europium (III) complexes (3 and 4) have been obtained reacting europium (III) nitrate and two polychlorotriphenylmethyl radicals properly functionalized with one (PTMMC⁻, 1) and six (PTMHC⁶⁻, 2) carboxylate groups, respectively. While complex 3 reveals a lamellar polar-apolar separated ion pair structure alternating PTM-based bilayers with nonaaquaeuropium cations ([Eu(H₂O)₉](PTMMC)₃(PTMMCH)₃ · 7H₂O · 6EtOH), complex 4 shows a one-dimensional chain-like structure with formula [Eu₂(PTMHC)(H₂O)₁₃] · 16H₂O · EtOH. Magnetic properties of both complexes were studied in the 2-300 K range, and show the presence of weak inter-radical antiferromagnetic interactions below 5 K.     

Functional model for catecholase-like activity: Synthesis, structure, spectra, and catalytic activity of iron(III) complexes with substituted-salicylaldimine ligands

Four new mononuclear iron(III) complexes with the substituted-salicylaldimine ligands, [Fe(L¹)(TCC)] (1), [Fe(L²)(TBC)] (2), [Fe(L³)(TBC)] (3) and [Fe(L⁴)(TCC)](CH₃CN) (4) (HL¹ = N′-(5-OH-salicylaldimine)-diethylenetriamine, HL² = (N′-(5-Cl-salicylaldimine)-diethylenetriamine, HL³ N′-(5-Br-salicyl-aldimine)-dipropylenetriamine, HL⁴ = (N′-3,5-Br-salicylaldimine)-dipropylenetriamine, H₂TCC = tetrachlorocatechol, and H₂TBC = tetrabromocatechol), were prepared and characterized by XRD, EPR, and Mössbauer spectroscopy. The coordination sphere of the Fe(III) in complexes 1-4 is a distorted octahedral with N₃O₃ donors set which constructed by the Schiff-base ligands and the catecholate substrates of TBC or TCC. The in situ prepared Fe(III) complexes [Fe(L¹)Cl₂], [Fe(L²)Cl₂], [Fe(L³)(Cl₂)], and [Fe(L⁴)Cl₂] in absence of TBC or TCC show a high catecholase-like activity for the oxidation of 3,5-DTBC to the corresponding quinone 3,5-DTBQ.